we have identified a transcript encoding a zinc binding functional anergy and not diminished viability. We also observed that addition of anti-IL-2 monoclonal antibody RING finger protein, GRAIL (gene related to anergy in to T cell clones cultured under activating conditions lymphocytes). Human and mouse GRAIL share homolblocked proliferation in response to antigen rechallenge ogy to other murine RING finger proteins as well as (data not shown). At the time of antigen rechallenge, to those from other species including A. thaliana, D.
activated, resting, and anergized T cell clones had melanogaster, and C. elegans, whose functions are equivalent TCR levels (data not shown). These data sugpoorly understood. Here we present data characterizing gested that the delivery of signals required to induce GRAIL function as an E3 ubiquitin ligase whose expresanergy was achieved within 4 hr of coculture and that sion results in diminished gene transcription of the cytoat this 4 hr time point transcriptional changes could be kine IL-2. Our studies demonstrate that GRAIL localizes observed in anergic T cells. to the transferrin recycling pathway and suggest a requirement for intact endocytic processes in order to GRAIL Is Expressed Early in the Induction of T Cell inhibit cytokine gene transcription.
Anergy In Vitro
In order to identify gene products specific to early events Results in the induction of CD4 ϩ T cell anergy, we used the in vitro model system described above and differential T Cell Anergy Is Rapidly Induced In Vitro display (ddPCR) to compare mRNA transcripts from To identify early gene products specific for the inductive T cell clones following 4 hr anergizing, resting, and actievents in anergy, we utilized a T cell-and APC-based vating conditions. Of the five differentially displayed system in vitro to induce phenotypic anergy, inhibition of gene products confirmed by quantitative PCR (qPCR) proliferation, and diminished IL-2 production following analysis to be expressed at higher levels in anergic T cell recall antigen challenge (Ruberti et al., 1992) . To function clones, only one transcript encoded an unknown protein as surrogate APCs, RT 7.7 fibroblasts were transfected with low to undetectable constitutive transcript levels to express the appropriate MHC in the presence or abin resting T cells ( Figure 1C ). A 32 P-labeled gene fragment sence of B7 to deliver either activating or anergy-inducwas used to screen a mouse anergic T cell library. A ing signals, respectively. These surrogate APCs were 2145 bp cDNA clone encoding a 1287 bp open reading cultured with the sperm whale myoglobin (SWM) reacframe was identified and called GRAIL. Following in vitro tive 3A T cell clone in the presence of B7 and SWM T cell, peptide, and surrogate APC coculture under anpeptide (activating), the presence of peptide but abergy-inducing conditions, GRAIL was rapidly transence of B7 (anergic), or in the presence of B7 but scribed. Northern blot analysis confirmed ddPCR data; absence of peptide (resting). T cell clones cocultured GRAIL mRNA level increased as early as 4 hr by 5-to under anergizing conditions for 4 or more hours, sepa-7-fold in anergized cultures as compared to resting or rated, rested, and rechallenged failed to proliferate (Figactivated cells (Figure 1D ). ure 1A) and to produce IL-2 (data not shown). The addition of IL-2 to the reactivation cultures restored GRAIL Induction in Ionomycin-Treated Cells Is proliferation ( Figure 1B ). These data suggest that abCalcineurin Dependent sence of proliferation in cells activated for 4-6 hr with
The calcium ionophore ionomycin has been previously used to mimic early events in the induction of T cell signal one in the absence of costimulation is a result of 
anergy (Macian et al., 2002). We additionally examined
Using a polyclonal antibody raised against the C-terminal GRAIL protein, we examined the kinetics of GRAIL GRAIL expression in T cells made unresponsive through ionomycin treatment. In cells treated with 1.5 M ionoinduction at the protein level. We observed markedly increased protein expression after 6 hr of ionomycin mycin for 6-18 hr, proliferation in response to antigen rechallenge was markedly diminished at both time treatment. GRAIL protein expression was undetectable in untreated T cells or in T cells treated with ionomycin points (Figure 2A ). Addition of IL-2 to these cultures at the time of antigen rechallenge restored proliferation to in the presence of cyclosporin A ( Figure 2E ). levels comparable to those of untreated cells ( Figure  2B ). After 6 hr of ionomycin treatment, GRAIL transcript GRAIL Contains a Highly Conserved Zinc Binding RING Finger was increased 3.3-fold compared to resting and activated cells by qPCR analysis and by 18 hr was rapidly Sequence analysis of the GRAIL cDNA revealed identity to a mouse brain cDNA clone (GenBank accession restored to resting levels ( Figure 2D ). While ionomycin treatment induced anergy and GRAIL expression in vitro, AB041548) that differed by a single nucleotide. The predicted translation product of GRAIL ( Figure 3A) is a 428 addition of 1 M cyclosporin A to ionomycin-treated cells markedly reduced anergy induction ( Figure 2C) . amino acid protein that exhibits homology to several zinc RING finger-containing proteins from mammalian We noted in parallel cyclosporin A addition blocked ionomycin-induced expression of GRAIL transcripts at 6 species as well as from a variety of invertebrate and plant species including C. elegans, A. thaliana, and the hr. Moreover, T cells activated with PMA and ionomycin also had minimal GRAIL transcript levels ( Figure 2D tered in a stretch of approximately 75 residues in the hGRAIL (AF394689) with 97% amino acid identity to murine GRAIL. Using various secondary structure pre-RING finger domain ( Figure 3B ), and this conservation across diverse species suggested functional signifidictive algorithms, we identified other putative structural motifs in addition to the zinc RING finger (C3H2C3 type) cance. Additionally, we cloned a human GRAIL homolog domain, including transmembrane, coiled-coil, and proused to examine its function in ligase activity. Substitution of two basic histidine residues with two basic aspartease-associated (PA) domains ( Figure 3C ). Analysis of GRAIL expression in multiple tissues by Northern blotagine residues that reside in the RING finger domain and coordinate zinc binding (H2N2 GRAIL) entirely abolished ting revealed that, in addition to its expression in anergic T cell clones, GRAIL message was found in tissues from autoubiquitination activity in vitro ( Figure 4C ). These data suggested that E3 ligase activity required an intact brain, kidney, heart, liver, ovary, testes, and thymus (Figure 3D) . In vitro translated GRAIL, endogenous GRAIL RING finger domain. From these studies, we observed that GRAIL fulfills two criteria for E3 ligase activity: the protein from hepatocytes, and GRAIL protein induced in anergic T cells was found to migrate between 62-66 ability to bind E2s and the ability to autocatalyze formation of higher molecular weight ubiquitin species in vitro. kDa. Glycosylation of GRAIL was demonstrated by tunicamycin treatment reducing GRAIL protein to a single A role for ubiquitination in the regulation of immune responses recently has become more evident. Cbl-b, band migrating at 46 kDa (data not shown).
an E3 and differential display described above. We now demtive GRAIL expression in liver ( Figure 3D ). Four murine onstrate that GRAIL is an E3 ubiquitin ligase induced homologs of human E2 ubiquitin transferase proteins under anergic conditions. were isolated by this procedure and identified by sequence analysis (data not shown). Therefore, we asked whether GRAIL could function in vitro as an E3 ubiquitin
GRAIL Inhibits Expression of IL-2 in T Cells
We identified GRAIL transcripts in anergic CD4 ϩ T cells ligase. During a ubiquitination reaction, ubiquitin is transferred from the E1 ubiquitin-activating enzyme characterized by deficient IL-2 cytokine production. To determine whether GRAIL expression was sufficient to (which forms the initial thiol-ester bond to ubiquitin) by an E2 ubiquitin transferase enzyme to an E3 ubiquitin confer this phenotype, IL-2 production was assayed following TCR engagement in MBP reactive T cell hybridoligase/conjugase via direct binding of the E2 with the E3 ligase. Substrate specificity is achieved via E3 ligase mas (ANTC) retrovirally transduced to express a cDNA of GRAIL bearing a C-terminal v5 epitope tag. Transduced substrate binding, which results in the mono-or polyubiquitination of the bound substrate. Therefore, one crite-T cell hybridomas were generated that expressed either wild-type or H2N2 RING finger mutant v5 tagged GRAIL rion with which to evaluate E3 ligase activity is the ability of the candidate E3 to directly bind an E2 ubiquitin transin the first cistron and GFP in the second cistron. The viral IRES enabled efficient transcription of both the first ferase, while a second criterion is ATP-dependent catalytic activity of ubiquitinating enzymes resulting in auand second cistrons resulting in comparable bicistronic transcription of GFP and GRAIL. T cell hybridomas toubiquitination (Hershko and Ciechanover, 1998; Glickman and Ciechanover, 2002).
transduced with vector, wild-type GRAIL, or H2N2 GRAIL were sorted by flow cytometry for equivalent GFP To test the ability of GRAIL to directly bind E2 ubiquitin-conjugating enzymes, GRAIL was expressed in E.
and clonotypic TCR V␤8 expression. In T cell hybridomas expressing wild-type GRAIL, we observed greatly coli as a recombinant human GRAIL-GST fusion protein lacking the signal sequence and the transmembrane reduced IL-2 production in response to anti-CD3 and anti-CD28 antibody activation when compared to IL-2 region. GRAIL-GST was bound to a column, and several recombinant E2s were run over the column in pull-down production in the same T cell hybridomas transduced with the vector control ( Figure 5A ). This inhibitory activity assays. Recombinant human GST-GRAIL bound several recombinant E2s including E2-H5a ( Figure 4A and data was lost in cells that expressed H2N2 mutant GRAIL containing the two amino acid substitutions in the RING not shown). Given that recombinant GRAIL binds E2 ubiquitin-transferring enzymes, we addressed the ability finger domain. Following stimulation, H2N2 mutanttransduced hybridomas exhibited IL-2 production comof GRAIL to act as an E3 ligase when coexpressed with these E2s in vitro by autocatalyzing the formation of parable to vector-transduced controls. Wild-type but not H2N2 mutant GRAIL was also found to inhibit IL-4 polyubiquitin chains. Autoubiquitinating activity of purified C-terminal GRAIL was examined in vitro through production following stimulation to less than 20% of levels seen in activated cells expressing vector alone expression of recombinant human His-tagged E1, various recombinant human E2s, ATP, and biotinylated ubi-( Figure 5B ). RNase protection assay demonstrated that this deficiency was due to diminished IL-2 and IL-4 tranquitin, followed by Western blotting with avidin-peroxidase. When hGRAIL-GST was assayed in the presence script levels ( Figure 5C ). To determine whether TCR proximal signaling events were required to inhibit cytoof E2-H5a or E2-H6 (and to a lesser extent with E2-H2), we observed a characteristic laddering pattern that kine production in the presence of full-length GRAIL, transduced T cell hybridomas were stimulated with PMA results from progressive polyubiquitination and formation of higher molecular weight ubiquitin conjugates and ionomycin to bypass cell surface activation. Inhibition of both IL-2 (0.899 U/ml vector versus 0.146 U/ml ( Figure 4B ) in an E1-and ATP-dependent manner ( Figure  4C ). Mutation analysis of the RING finger domain was wild-type GRAIL) and IL-4 (0.073 ng/ml vector versus That GRAIL is induced in a highly regulated manner A second possible mechanism for GRAIL regulation in peripheral CD4 ϩ T cells while constitutive GRAIL exof mitogenic signal delivery could be through GRAILpression is observed in the CNS, kidney, and liver sugmediated ubiquitination of substrate, resulting in subgests tissue-specific substrate interactions, regulation strate degradation via the proteosome. GRAIL is a type of GRAIL itself at a posttranslational level, or, most in-I transmembrane protein, suggesting that its N-terminal triguingly, that the program of T cell anergy is similar protease-associated domain would be internal to an to regulatory pathways in these organs. Understanding endocytic vesicle and that the C terminus C3H2C3 RING GRAIL function in concert with other anergy-specific finger domain would project into the cytosolic lumen.
GRAIL Localizes to the Internal Pool of the Transferrin Recycling Endosomal Pathway (A) NIH 3T3 retrovirally transduced lines expressing wild-type GRAIL with a C-terminal v5 epitope tag were used for immunofluorescence analysis of subcellular GRAIL (100ϫ oil). Confocal secions of .5 M were taken at 100ϫ magnification of NIH 3T3 cells costained (C, F, and I) for GRAIL-v5 (B, E, and H) and anti-GRP78 (ER) (A), anti-syntaxin 5 (Golgi) (D), or anti-Rab7 (late endosomes) (G). Recycling endosomal localization in NIH 3T3 cells was assayed after transferrin uptake for 30 min. Shown are .5 M confocal sections for GRAIL-V5 (K) and Texas Red-transferrin (J), with overlay (L).
genes will expose the functional mechanisms that unThis positioning affords the possibility of its interaction derlie anergy induction in T cells. In light of GRAIL E3 with numerous cytosolic proteins that may be substrates ligase activity, endocytic residence, and domain homolfor ubiquitination and degradation.
ogy, understanding GRAIL function and substrate assoThe coordinated regulation of mitogenic signaling on ciation is likely to reveal highly conserved mechanisms endosomes has been established for several signaling for rapidly altering cell fate in diverse cellular contexts. pathways, including components of those pathways downstream of CD28 such as JNK and WASP (Cavalli seeded for antibody stimulation into 1 ml RPMI-C onto a 6-well done using EXPASY and NCBI-Blast. Drosophila Goliath (G1) protein precoated with 5 g/ml anti-CD3 and anti-CD28 antibodies (BD (AAA28582) (35% identity over 191 amino acids (aa), mouse g1-Pharmingen). ELISA supernatants were harvested at 18-24 hr. For related protein (g1rp) (AAF05310) (41%, 315 aa), the uncharacterized PMA-ionomycin stimulation, 1 ϫ 10 6 cells/ml cells were seeded in human KIAA1214 protein (BAA86528) (38%, 354 aa), an uncharacter-RPMI-C with 1 g/ml PMA plus 1 g/ml ionomycin; supernatants ized C. elegans protein (AAC26923) (32%, 193 aa), and a mouse were harvested at 6 hr. Europium Sandwich ELISA (Pharmingen and RING zinc finger protein (AAC03770) (24% identity, 336 aa) were Wallac) was performed on triplicate wells in 96-well plates (Nunc). aligned. Secondary structural predictions were made using algoBased on standard curves, the lower limits of detection were 0.078 rithms available at the ExPASY website and conserved domain dataunits/ml for IL-2 and .01 ng/ml for IL-4. Actual experimental values base at NCBI.
for IL-2 ranged between .15 and 2.5 U/ml activity and for IL-4 between .0001 (below detectable limits) and .1 ng/ml under anti-CD3 anti-CD28 stimulation conditions. Western Blot Analysis of GRAIL Expression Recombinant C-terminal GRAIL protein was expressed in bacteria RPA as a GST fusion (pET41 vector, Novagen); purified protein was used The Riboquant Multiprobe RNase Protection System was used to gento produce rabbit polyclonal antiserum (Zymed). Affinity-purified erate mouse cytokine probe mCK-1, and standard Riboquant procerabbit polyclonal antibody against GRAIL was screened against hedures (Pharmingen) were used to detect products in 5 g total RNA. patocyte and GRAIL-expressing T cell hybridomas by Western blot and immunofluorescence analysis. Brij 96V lysis buffer was used for cell lysis.
Immunofluorescence See Supplemental Experimental Procedures at http://www.immunity. com/cgi/content/full/18/4/535/DC1.
Northern Blot Analysis of GRAIL Expression
Northern analysis was performed on total RNA from 11.3.7 T cells Concanavalin A and Latrunculin B Treatment treated for 4 hr under resting, activating, or anergizing conditions. 1 ϫ 10 6 ANTC cells were seeded with 6-8 ϫ 10 6 B10.PL female Membranes were hybridized with a 1.8 kb random-primed 32 P-labeled (Jackson) irradiated splenocytes in the presence of 2.5 g/ml conca-GRAIL cDNA fragment according to standard protocols, stripped, navalin A (Sigma). For anti-CD3, anti-CD28 activation cells were and reprobed with the DECAprobe-GAPDH-Mouse cDNA fragment cultured with anti-CD3 and anti-CD28 as described above but with (Ambion) to assess loading. For multitissue analysis, GRAIL ORF addition of either 2.5 g/ml concanavalin A or .1 g/ml Latrunculin B. cDNA was cloned into pCR4 (Invitrogen) and linearized, and 32 P-UTPlabeled antisense transcripts were generated using T3 polymerase (StripAble RNA probe synthesis, Ambion). Full-length antisense Acknowledgments mouse GRAIL probe was hydridized at 10 6 cpm/ml to Ambion's FirstChoice Mouse Blot 1 (Ambion). The blot was stripped and reWe gratefully acknowledge that anti-syntaxin 5 and 6 polyclonal antibodies were provided by the lab of Richard Scheller, anti-rab 7 probed with antisense probe generated from pTRI-␤-actin-mouse control template (Ambion).
and anti-rab 9 polyclonal antibodies were a gift of Susan Pfeffer, and the phoenix packaging cell line was provided by Garry Nolan.
